Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C30H28O8 |
| Molecular Weight | 516.5385 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)C1=C(O)C(CC2=C(O)C(C(=O)\C=C\C3=CC=CC=C3)=C4OC(C)(C)C=CC4=C2O)=C(O)C(C)=C1O
InChI
InChIKey=DEZFNHCVIZBHBI-ZHACJKMWSA-N
InChI=1S/C30H28O8/c1-15-24(33)19(27(36)22(16(2)31)25(15)34)14-20-26(35)18-12-13-30(3,4)38-29(18)23(28(20)37)21(32)11-10-17-8-6-5-7-9-17/h5-13,33-37H,14H2,1-4H3/b11-10+
Rottlerin is a principal phenolic compound of the Kamala plant Mallotus philippinensis. It was thought to be a selective inhibitor of PKCδ (protein kinase Cδ) (IC50=3-6 uM). It also inhibits PKCα, PKCβ, PKCγ, PKCε, PKCη, PKCζ and eEF2K (CaMK III) (IC50 = 5.3 uM). In HT1080 human fibrosarcoma cells, rottlerin induces apoptosis and autophagy via a PKCδ-independent pathway. When tested on HERG channels, rottlerin increased both step and tail HERG current by leftward shifting the voltage and dependence of HERG activation and slowing channel deactivation. Rottlerin is an inhibitor of Chk2, MAPKAPK-2, Pim-3, PKCλ, PKCθ, Plk, PRAK, SRPK1 and an activator of AMPK and HERG. There have been a number of studies published with evidence against the role of Rotterlin as a specific PKCδ inhibitor.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Q12809|||Q9BUT7 Gene ID: 3757.0 Gene Symbol: KCNH2 Target Organism: Homo sapiens (Human) |
0.34 µM [EC50] | ||
Target ID: CHEMBL2996 |
3.0 µM [IC50] | ||
Target ID: CHEMBL3094 |
1.9 µM [IC50] | ||
Target ID: CHEMBL2208 |
5.4 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration. | 2003 |
|
| Induction of cIAP-2 in human colon cancer cells through PKC delta/NF-kappa B. | 2003 Dec 19 |
|
| The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. | 2003 Jan 3 |
|
| Allyl alcohol activation of protein kinase C delta leads to cytotoxicity of rat hepatocytes. | 2003 May |
|
| Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells. | 2004 Aug 15 |
|
| Blockade of PKCdelta proteolytic activation by loss of function mutants rescues mesencephalic dopaminergic neurons from methylcyclopentadienyl manganese tricarbonyl (MMT)-induced apoptotic cell death. | 2004 Dec |
|
| Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells. | 2004 Dec 1 |
|
| PKC-epsilon regulation of extracellular signal-regulated kinase: a potential role in phenylephrine-induced cardiocyte growth. | 2004 Jun |
|
| Localization of VEGFR-2 and PLD2 in endothelial caveolae is involved in VEGF-induced phosphorylation of MEK and ERK. | 2004 May |
|
| Gefitinib ("Iressa", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells. | 2005 Apr |
|
| Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis. | 2005 Aug |
|
| Protein kinase Ctheta activity is involved in the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced signal transduction pathway leading to apoptosis in L-MAT, a human lymphoblastic T-cell line. | 2005 Feb |
|
| Phosphorylation-regulated nucleocytoplasmic trafficking of internalized fibroblast growth factor-1. | 2005 Feb |
|
| PKC delta-induced activation of MAPK pathway is required for bFGF-stimulated proliferation of coronary smooth muscle cells. | 2005 Jul 1 |
|
| Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue. | 2005 May |
|
| Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells. | 2005 May 20 |
|
| Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. | 2006 |
|
| Piceatannol upregulates endothelial heme oxygenase-1 expression via novel protein kinase C and tyrosine kinase pathways. | 2006 Feb |
|
| Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells. | 2006 Oct |
|
| Microarray-based kinase inhibition assay by gold nanoparticle probes. | 2007 Jan 15 |
|
| Involvement of protein kinase Cdelta in iron chelator-induced IL-8 production in human intestinal epithelial cells. | 2007 Jan 9 |
|
| Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase. | 2007 Jun |
|
| Curcumin-induced GADD153 upregulation: modulation by glutathione. | 2007 May 15 |
|
| Chlorpromazine attenuates pancreatic beta-cell function and mass through IRS2 degradation, while exercise partially reverses the attenuation. | 2008 Jul |
|
| Heme oxygenase-1 mediates the anti-inflammatory effect of Curcumin within LPS-stimulated human monocytes. | 2008 Jun |
|
| Protein kinase C-delta mediates down-regulation of heterogeneous nuclear ribonucleoprotein K protein: involvement in apoptosis induction. | 2009 Nov 15 |
|
| Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. | 2009 Sep 22 |
|
| Puerarin suppresses AGEs-induced inflammation in mouse mesangial cells: a possible pathway through the induction of heme oxygenase-1 expression. | 2010 Apr 15 |
|
| PKC-δ mediates TCDD-induced apoptosis of chondrocyte in ROS-dependent manner. | 2010 Nov |
|
| 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea inhibits tumor cell invasion by regulating protein kinase C-delta-dependent matrix metalloproteinase-9 expression. | 2010 Oct 5 |
|
| Protective role of taurine against arsenic-induced mitochondria-dependent hepatic apoptosis via the inhibition of PKCdelta-JNK pathway. | 2010 Sep 7 |
|
| All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-delta. | 2011 Aug |
|
| Dual function of protein kinase C (PKC) in 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced manganese superoxide dismutase (MnSOD) expression: activation of CREB and FOXO3a by PKC-alpha phosphorylation and by PKC-mediated inactivation of Akt, respectively. | 2011 Aug 26 |
|
| Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. | 2011 May |
|
| Rottlerin induces apoptosis of HT29 colon carcinoma cells through NAG-1 upregulation via an ERK and p38 MAPK-dependent and PKC δ-independent mechanism. | 2012 Apr 15 |
|
| PKCδ mediates paraquat-induced Nox1 expression in dopaminergic neurons. | 2013 Aug 2 |
|
| Isorhamnetin protects against oxidative stress by activating Nrf2 and inducing the expression of its target genes. | 2014 Jan 15 |
|
| Naringin protects against anoxia/reoxygenation-induced apoptosis in H9c2 cells via the Nrf2 signaling pathway. | 2015 Apr |
|
| A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression. | 2015 May |
|
| Protein kinase Cδ mediates trimethyltin-induced neurotoxicity in mice in vivo via inhibition of glutathione defense mechanism. | 2016 Apr |
Sample Use Guides
Xenograft tumor
model in nude mice: mice were randomized into 4 treatment groups (control, DMSO, rottlerin 4 mg/kg, and rottlerin 2 mg/kg) with 5 mice per group. All the mice were
injected intraperitoneally daily for 4 weeks. Tumors were smaller in the experimental
groups than the control and DSMO groups, and tumors
were smaller in the rottlerin 4 mg/kg group than the rottlerin
2 mg/kg group.
Route of Administration:
Intraperitoneal
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID30231502
Created by
admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
|
PRIMARY | |||
|
Rottlerin
Created by
admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
|
PRIMARY | |||
|
82-08-6
Created by
admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
|
PRIMARY | |||
|
E29LP3ZMUH
Created by
admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
|
PRIMARY | |||
|
8899
Created by
admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
|
PRIMARY | |||
|
5281847
Created by
admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
|
PRIMARY | |||
|
C085746
Created by
admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
|
PRIMARY | |||
|
94525
Created by
admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
|
PRIMARY | |||
|
m9675
Created by
admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
|
PRIMARY | Merck Index | ||
|
56346
Created by
admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
|
PRIMARY | |||
|
201-395-4
Created by
admin on Fri Dec 15 19:00:15 GMT 2023 , Edited by admin on Fri Dec 15 19:00:15 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
